News & Updates

Show Multimedia Only

Apixaban may confer survival benefit for COVID-19 inpatients

05 Aug 2020 by

The direct oral anticoagulant apixaban may help prevent deaths when given at prophylactic or therapeutic doses in hospitalized COVID-19 patients with elevated D-dimer levels, according to an analysis presented during the ISTH 2020 Congress.

Apixaban may confer survival benefit for COVID-19 inpatients

05 Aug 2020

Physical distancing, face masks key to reducing COVID-19 spread

05 Aug 2020 by

Physical distancing of ≥1 m and use of face masks and eye protection reduced the risk of COVID-19 transmission in healthcare settings and the community, according to a systematic review and meta-analysis.

Physical distancing, face masks key to reducing COVID-19 spread

05 Aug 2020

Managing liver derangement in COVID-19: Recommendations for clinicians

05 Aug 2020 by

In view of the prevalence and prognostic significance of liver derangement in patients with coronavirus disease 2019 (COVID-19), the Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic has issued practical recommendations on 12 clinical scenarios commonly encountered by physicians.

Managing liver derangement in COVID-19: Recommendations for clinicians

05 Aug 2020

COVID-19 restrictions also suppress other respiratory viruses

05 Aug 2020 by

Public health measures to stop the spread of the coronavirus disease 2019 (COVID-19) may have the unintended benefit of also reducing hospitalizations due to other viral respiratory infections, according to a new study.

COVID-19 restrictions also suppress other respiratory viruses

05 Aug 2020

Early preparedness, intensive response key to combating COVID-19

05 Aug 2020 by

Both Malaysia and Kerala (a state in India) have relatively low fatality rates of COVID-19 as a result of preparing early and intensively even before they received the first patient.

Early preparedness, intensive response key to combating COVID-19

05 Aug 2020

Global race for COVID-19 vaccine gains momentum

04 Aug 2020 by

The global race for a COVID-19 vaccine moves at an unprecedented speed, buoyed by public pressure and geopolitical crosscurrents that were punctuated by deaths and infections around the world.

Global race for COVID-19 vaccine gains momentum

04 Aug 2020

Children with COVID-19 at risk of developing severe disease requiring ICU admission

04 Aug 2020 by

Unlike previously thought, severe disease appears to be common among children and adolescents with the novel coronavirus disease (COVID-19), according to a new study.

Children with COVID-19 at risk of developing severe disease requiring ICU admission

04 Aug 2020

Mavrilimumab improves outcomes in COVID-19 pneumonia with hyperinflammation

03 Aug 2020 by

Adding the anti-GM-CSF* receptor-α monoclonal antibody mavrilimumab to standard care (SC) improved clinical outcomes in patients with severe coronavirus disease 2019 (COVID-19) pneumonia and systemic hyperinflammation who were not under mechanical ventilation (MV), an Italian study has shown.

Mavrilimumab improves outcomes in COVID-19 pneumonia with hyperinflammation

03 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Apixaban may confer survival benefit for COVID-19 inpatients

Apixaban may confer survival benefit for COVID-19 inpatients

Physical distancing, face masks key to reducing COVID-19 spread

Physical distancing, face masks key to reducing COVID-19 spread

Managing liver derangement in COVID-19: Recommendations for clinicians

Managing liver derangement in COVID-19: Recommendations for clinicians

COVID-19 restrictions also suppress other respiratory viruses

COVID-19 restrictions also suppress other respiratory viruses

Early preparedness, intensive response key to combating COVID-19

Early preparedness, intensive response key to combating COVID-19

Global race for COVID-19 vaccine gains momentum

Global race for COVID-19 vaccine gains momentum

Children with COVID-19 at risk of developing severe disease requiring ICU admission

Children with COVID-19 at risk of developing severe disease requiring ICU admission

Mavrilimumab improves outcomes in COVID-19 pneumonia with hyperinflammation

Mavrilimumab improves outcomes in COVID-19 pneumonia with hyperinflammation